Key points are not available for this paper at this time.
You have accessJournal of UrologyStone Disease: Medical p=0.929), groin pain (4.33±2.59 vs. 4.02±2.44; p=0.758), pain frequency (4.70±2.33 vs. 5.22±2.28; p=0.564) or nausea intensity (1.18±1.63 vs. 1.98±2.01; p=0.259) did not vary significantly between groups. 23 patients completed the USSQ with no difference in total (30.23±6.48 vs. 29.3±11.02, p=0.802) nor sub-domain scores. 13 TENS patients completed the EQ; 12 (92.3%) noted positive experiences with 10 (76.9%) preferring TENS to medication partially or entirely and 9 (69.2%) attributing TENS to decreased pain symptoms. None reported decreased nausea or urinary symptoms. CONCLUSIONS: While patients who received a TENS device reported subjective improvement of their symptoms and decreased pain medication use, these differences were not evident when compared to a control group. There remains strong interest by patients in non-pharmacologic symptom management options, but in our study the use of a TENS device does not seem to decrease symptom scores and pain medication use. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e416 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Rohit Tejwani More articles by this author Shaun Hager More articles by this author Ryan Sun More articles by this author Nishant Doctor More articles by this author Sneha Mohile More articles by this author Timothy Chang More articles by this author Simon Conti More articles by this author Expand All Advertisement PDF downloadLoading ...
Tejwani et al. (Mon,) studied this question.